LINC00886

Across TCGA pan-cancer cohorts, LINC00886 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LINC00886 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC00886 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00886 expression acts as an unfavorable survival marker.

COAD, LUSC, and UCEC are the cancer types where LINC00886 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.159	0.801	.001	36	view →
LUSC	OS	Median	III,IV	0.054	0.768	<.001	9	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

LINC00886–COAD (OS)

Open the COAD breakdown →